The NHS lung cancer drug that ‘stops tumours growing’

Historic breakthrough as Sotorasib found to successfully target ‘death star’ mutation

An x-ray of lungs
(Image credit: American Cancer Society via Getty Images)

NHS lung cancer patients will be the first in Europe to receive a revolutionary new drug that can stop tumour growth.

The Times reported that Sotorasib will be fast-tracked to NHS patients after trials found that the medication halted the growth of lung cancer for seven months.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up